GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its ...
Wells Fargo analyst Larry Biegelsen raised the firm’s price target on GE HealthCare (GEHC) to $103 from $96 and keeps an Overweight rating on ...
GE HealthCare Technologies Inc. closed 2.73% short of its 52-week high of $94.80, which the company achieved on February 13th.
GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President an ...
Reports Q4 revenue $5.32B, consensus $5.33B. GE HealthCare President and CEO Peter Arduini said, “We were pleased with the strong momentum in orders, backlog and book-to-bill th ...
Wuensch rates GE HealthCare stock at Buy with a $103 price target. Coming into Thursday, GE HealthCare stock has risen about ...
Shares of GE HealthCare (NASDAQ:GEHC) jumped 9% Thursday after the company issued its Q4 earnings report and 2025 forecast. For Q4, the company posted non-GAAP EPS of $1.45 on revenue of $5.32B.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Paige traveled all the way to New Orleans for Super Bowl 59, where she cheered on the winning team (who beat the Kansas City Chiefs), hung out, and appeared to have an amazing time. She took to ...
The Harvard Pilgrim Health Care Institute is proud to announce the launch of the Center for Sepsis Epidemiology and Prevention Studies (SEPSIS).
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results